Results 221 to 230 of about 3,692,753 (275)

Design of galectin-1-conjugated nanoparticles as potential immunomodulatory agents. [PDF]

RSC Med Chem
Ghosh C, Yao L, Sigler M, Di Lella S, Cagnoni AJ, Rabinovich GA, Seeberger PH.   +6 more
europepmc   +1 more source

The R203W substitution drives PACS‐1 syndrome by disrupting intramolecular regulation

The FEBS Journal, EarlyView.
The middle region (MR) of PACS‐1 controls engagement with specific partner proteins. This manuscript presents the structure of the Furin binding region (FBR) and how interactions with partners are regulated through the interplay between a basic patch in the FBR and an acidic cluster in the MR.
Troy C. Krzysiak, In‐Ja L. Byeon, Ryan Ponticelli, Mary E. Lucas, Lariah Thompson, Christopher DeHaven, Gary Thomas, Angela M. Gronenborn   +7 more
wiley   +1 more source

The Dual Anaplerotic Model (DAM): Integral Roles of Pyruvate Carboxylase and the GABA Shunt in Beta Cell Insulin Secretion. [PDF]

Life (Basel)
Grubelnik V, Zmazek J, Marhl M.
europepmc   +1 more source

Cross-Linking PEG Microgels with Mesoporous Organosilica Nanoparticles to Engineer Microporous Annealed Particle Scaffold Properties. [PDF]

ACS Omega
Zuidema JM, Ajò A, Carofiglio M, De Cola L.   +3 more
europepmc   +1 more source

Cytopathological evaluation of serous effusions using the ISRSFC system: Risk of malignancy and demographic associations in a Saudi cohort. [PDF]

Saudi Med J
Salih MM, Abdullah Alotaibi S, Al Talhi AM, Hassan MA, Bhaket KM, Bakhsh NA.   +5 more
europepmc   +1 more source

Endosome-phagophore linking assemblies for the degradation of membrane/extracellular proteins. [PDF]

Nat Commun
Wang P, Sun H, An P, Tang P, Liu Q, Tang Z, Lv T, Ruan J, Zhen X, Han L.   +9 more
europepmc   +1 more source

From malnutrition-related diabetes mellitus to 'type 5 diabetes': phenotypic variation, not reclassification. Reply to Gupta L, Misra A [letter]. [PDF]

Diabetologia
Trimble ER, Phillips DIW, Balcha SA.
europepmc   +1 more source